|
Digital Turbine, Inc.
June 6, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Digital Turbine Inc. ("Digital Turbine” or the "Company”) (NASDAQ: APPS). Digital Turbine provides media and mobile communication products and solutions for mobile operators, application advertisers, publishers, device original equipment manufacturers (OEMs), and other third parties.
|
|
MSP Recovery, Inc.
June 2, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MSP Recovery Inc. ("MSP Recovery” or the "Company”) (NASDAQ: MSPR; MSPRZ), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery company that purports to use data-driven solutions to secure recoveries against responsible parties for healthcare reimbursement.
|
|
Enochian BioSciences, Inc.
May 26, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Enochian BioSciences Inc. (“Enochian” or the “Company”) (Nasdaq: ENOB), a company that purports to be biotechnology company.
|
|
Inotiv, Inc.
May 25, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inotiv Inc. ("Inotiv” or the "Company") (NASDAQ: NOTV).
|
|
IonQ
May 6, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of IonQ ("IonQ or the "Company") (IONQ: NYSE), a company that was formed by the September 2021 business combination with dMY Technology Group, Inc. III (“dMY III”) (NYSE: DMYI), a publicly traded special acquisition company.
|
|
Lilium N.V. f/k/a Qell Acquisition Corp.
May 4 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Lilium N.V. f/k/a Qell Acquisition Corp. (“Lilium” or the “Company”) (NASDAQ: LILM; QELL). A complaint has been filed on behalf of investors who purchased or otherwise acquired Lilium securities between March 30.2021 through March 14, 2022.
|
|
Teladoc Health, Inc.
April 29 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC).
|
|
Molecular Partners AG
April 29 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Molecular Partners AG ADRs ("Molecular Partners" or the "Company") (NASDAQ:MOLN).
|
|
DENTSPLY SIRONA Inc.
April 20, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY), a company that purports to be the world’s largest manufacturer of professional dental products and technologies.
|
|
Arqit Quantum, Inc.
April 19, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Arqit Quantum Inc. (“Arqit” or the “Company”) (Nasdaq: ARQQ, ARQQW). Arqit is a cybersecurity company that purports to be developing quantum encryption technology to secure against cyber attacks.
|
|
TransUnion
April 13, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TransUnion (NYSE: TRU).
|
|
Embark Technology, Inc.
April 12, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Embark Technology, Inc. f/k/a Northern Genesis Acquisition Corp. (“Embark” or the “Company”) (NASDAQ: EMBK), a company that develops self-driving solutions for the trucking industry in the U.S. A complaint has been filed on behalf of investors who purchased or otherwise acquired Embark securities stock between January 12, 2021 and January 5, 2022.
|
|
Lucid Group, Inc.
April 11, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ: LCID), a company that designs, engineers, builds, and sells luxury electric vehicles. A complaint has been filed on behalf of investors who purchased or otherwise acquired Lucid common stock between November 15, 2021 and February 28, 2022.
|
|
Kaleido Biosciences, Inc.
April 11, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Kaleido Biosciences, Inc. (“Kaleido Biosciences” or the “Company”) (Nasdaq: KLDO).
|
|
NeoGenomics, Inc.
March 29, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (Nasdaq: NEO), a company that operates a network of clinical laboratories providing cancer genetics diagnostic testing services.
|
|
Grab Holdings, Inc.
March 24, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Grab Holdings Limited (“Grab” or the “Company”) (NASDAQ: GRAB). Grab purportedly offers a superapp that operates primarily across the deliveries, mobility, and digital financial services sectors in Southeast Asia. A complaint has been filed on behalf of investors who purchased or otherwise acquired Grab securities between November 12, 2021 and March 3, 2022, inclusive (the “Class Period”).
|
|
Affirm Holdings, Inc.
March 21, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). A complaint has been filed on behalf of investors who purchased or otherwise acquired Affirm securities on February 10, 2022 after the Company sent a Tweet concerning its Second Quarter 2022 financial results at approximately 1:15pm EST (the “Class Period”).
|
|
Butterfly Network, Inc.
March 1, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Butterfly Network, Inc. f/k/a/ Longview Acquisition Corp. (“Butterfly” or the “Company”) (NYSE: BFLY). A complaint has been filed on behalf of investors who purchased or otherwise acquired Butterfly securities between February 16, 2021 and November 15, 2021.
|
|
Acutus Medical, Inc.
March 1 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). A complaint has been filed on behalf of investors who purchased or otherwise acquired Acutus common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”).
|
|
SunPower Corporation
March 2, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR). A complaint has been filed on behalf of investors who purchased or otherwise acquired SunPower securities between August 3, 2021 and January 20, 2022, inclusive (the “Class Period”).
|
|
Astra Space, Inc.
February 28, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Astra Space Inc. f/k/a/ Holicity Inc. (“Astra” or the “Company”) (NASDAQ: ASTR). A complaint has been filed on behalf of investors who purchased the publicly traded securities of Astra between February 2, 2021 through December 29, 2021.
|
|
TaskUS, Inc.
January 26, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TaskUs, Inc. (“TaskUS” or the “Company”) (NASDAQ: TASK), a company that provides outsourced digital services.
|
